Doctors Note Logo

Published on: 9/17/2026

How long should I give Lexapro before switching to another antidepressant?

Most clinicians recommend giving Lexapro (escitalopram) at least 4 to 6 weeks at an adequate dose before deciding it isn't working, since early side effects often fade by week 2 and full antidepressant benefit can take 6 to 8 weeks. If you notice no improvement at all by week 4, a dose increase is usually tried first, while partial improvement often warrants waiting the full 8 weeks before switching. Switching too soon is one of the most common reasons people cycle through multiple antidepressants without relief, though worsening mood, new suicidal thoughts, or intolerable side effects are reasons to contact your prescriber right away rather than waiting. Timing also depends on your dose, how long you've been at it, and whether a cross-taper or washout period is needed, so there are several important factors to consider before making a change. See below to understand more.

If you're unsure whether what you're feeling is a sign your medication needs more time, a dose adjustment, or a different approach entirely, it helps to get a structured read on your symptoms before your next appointment. A free, instant, online symptom check asks the same kinds of questions a clinician would, then helps you organize your experience into clear information you can bring to your prescriber. That means less guessing, better questions, and a faster path to the treatment that actually works for you.

Last reviewed for medical accuracy: 09/17/2026

answer background

Explanation

How Long to Give Lexapro Before Switching Antidepressants

Deciding when to switch from Lexapro (escitalopram) to another antidepressant can feel overwhelming, especially if you’re asking, “why am i still depressed even on lexapro?” Below is a clear, step-by-step guide based on credible clinical guidelines and expert consensus.

1. Understand the Typical Timeline for Lexapro

  • Initial effects (2–4 weeks):
    You may notice small improvements in sleep, appetite or energy.
  • Full therapeutic effect (6–12 weeks):
    Most people need at least 6–8 weeks at a therapeutic dose before determining if Lexapro is truly helping. Some patients report the full benefit closer to 12 weeks.

Key point: Don’t judge Lexapro too early. Early side effects (nausea, headache, fatigue) often improve before mood lifts do.

2. Monitor Your Progress

Regular check-ins with your prescriber help track real change:

  • Week 2:
    Assess side effects and tolerability.
  • Week 4–6:
    Look for early signs of mood improvement (less anxiety, better sleep).
  • Week 8–12:
    Evaluate overall mood, functionality and quality of life.

Keep a simple mood diary or checklist of symptoms. Share it with your doctor.

3. Common Reasons “Why Am I Still Depressed Even on Lexapro?”

  1. Dose too low:
    Lexapro is usually started at 10 mg/day and can be increased to 20 mg/day. If you’re on a low dose, there may not be enough drug in your system.
  2. Poor adherence:
    Missing doses or stopping early can prevent steady blood levels.
  3. Individual metabolism:
    Genetic factors affect how quickly you process SSRIs—some people need higher or more frequent dosing.
  4. Coexisting conditions:
    Thyroid issues, vitamin D deficiency, or sleep apnea may mask or worsen depression.
  5. Other mental health diagnoses:
    Bipolar disorder, PTSD or ADHD often need tailored treatments or add-on medications.
  6. Lifestyle factors:
    Chronic stress, poor diet, lack of exercise and social isolation can undermine drug response.
  7. Psychological treatments:
    Medication alone may not be enough—therapy (CBT, interpersonal) boosts outcomes.

4. When to Consider Staying the Course

If you’ve given Lexapro at least 6–8 weeks at a moderate dose and you’re seeing:

  • Gradual improvement in mood
  • Better sleep or appetite
  • Reduced anxiety or irritability

…then continuing makes sense. Often, a slow build in benefit continues beyond week 8.

5. When to Think About Switching

Consider a switch if, after 8–12 weeks at an optimal dose, you have:

  • Less than 25 % improvement in core symptoms (persistent sadness, hopelessness)
  • Intolerable side effects (sexual dysfunction, weight gain, severe fatigue)
  • No noticeable gains in daily functioning

Steps Before Switching

  1. Confirm adherence and dose:
    Make sure you’ve been taking Lexapro as prescribed, without missed doses.
  2. Screen for other issues:
    A hormone panel, sleep study or vitamin screen can reveal treatable factors.
  3. Add psychotherapy or lifestyle changes:
    Cognitive-behavioral therapy, exercise, meditation and improved sleep hygiene often amplify drug effects.
  4. Consider augmentation:
    Some patients do better when an SSRI is combined with bupropion or low-dose atypical antipsychotics under close supervision.

If you’re still stuck after these steps, a switch to another SSRI (e.g., sertraline, fluoxetine) or a different class (e.g., SNRI like venlafaxine) may be warranted.

6. How to Switch Safely

  • Taper Lexapro:
    Slowly reduce your current dose over 1–2 weeks to minimize withdrawal or discontinuation symptoms.
  • Cross-titrate:
    Begin the new medication at a low dose while tapering Lexapro, under your doctor’s guidance.
  • Monitor for interactions:
    Some drugs can cause serotonin syndrome if overlapped too long. Always follow your prescriber’s plan closely.
  • Schedule follow-up visits:
    Check in at 2, 4 and 8 weeks after starting the new antidepressant.

7. Keeping Anxiety in Check Without Sugar-Coating

  • It’s normal to feel uncertain when one treatment doesn’t work.
  • Rough patches can occur even on effective medication.
  • Be open with your doctor about side effects—don’t tough it out alone.
  • Trust that adjustments are common: about one-third of people need more than one trial to find the right drug or dose.

8. Additional Support: Symptom Checking

If you’re unsure about your symptoms or next steps, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. It can help you organize your concerns and decide what to discuss at your next appointment.

free, online symptom check, using the doctor approved Ubie Symptom Checker

9. When to Seek Immediate Help

  • Thoughts of harming yourself or others
  • Severe suicidal ideation or plan
  • Intense panic attacks that limit breathing or cause chest pain
  • New, severe mood swings or confusion
  • Any life-threatening or serious symptoms

If you experience any of these, seek medical attention immediately—call your local emergency services or go to the nearest emergency department.

10. Final Takeaway

  • Give Lexapro at least 6–8 weeks at a therapeutic dose before deciding it’s not working.
  • Track your symptoms, stay consistent with dosing, and combine medication with therapy and lifestyle changes.
  • If you’re still asking, “why am i still depressed even on lexapro?”, discuss dose adjustments, augmentation or switching with your doctor.
  • Use the Ubie Symptom Checker to prepare for visits.
  • Always speak to a doctor about life-threatening or serious issues. Your health is too important to leave to chance.

(References)

  • * Hayasaka Y, Purgato M, Magni LR, Ogawa Y, Takeshima N, Cipriani A, Barbui C, Leucht S, Furukawa TA. Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials. J Affect Disord. 2015 Jul 15;180:179-84. doi: 10.1016/j.jad.2015.03.021. Epub 2015 Mar 31. PMID: 25911132.

  • * Cipriani A, Zhou X, Del Giovane C, Hetrick SE, Qin B, Whittington C, Coghill D, Zhang Y, Hazell P, Leucht S, Cuijpers P, Pu J, Cohen D, Ravindran AV, Liu Y, Michael KD, Yang L, Liu L, Xie P. Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis. Lancet. 2016 Aug 27;388(10047):881-90. doi: 10.1016/S0140-6736(16)30385-3. Epub 2016 Jun 8. PMID: 27289172.

  • * Yoon H, Oh DJ, Suh HS, Lee KU, Lim SW, Lee JY, Yang JC, Lee JH, Ha J, Lee BH, Kang SG, Yoon HK, Moon J, Bae SM, Kwon Y, Kim HC, Oh KS. Korean Guidelines for the Pharmacological Treatment of Social Anxiety Disorder: Initial Treatment Strategies. Psychiatry Investig. 2018 Feb;15(2):147-155. doi: 10.30773/pi.2017.05.01. Epub 2017 Nov 29. PMID: 29475215; PMCID: PMC5900408.

  • * Bahar MA, Lanting P, Bos JHJ, Sijmons RH, Hak E, Wilffert B. Impact of Drug-Gene-Interaction, Drug-Drug-Interaction, and Drug-Drug-Gene-Interaction on (es)Citalopram Therapy: The PharmLines Initiative. J Pers Med. 2020 Nov 28;10(4). doi: 10.3390/jpm10040256. Epub 2020 Nov 28. PMID: 33260705; PMCID: PMC7720126.

  • * Hetrick SE, McKenzie JE, Bailey AP, Sharma V, Moller CI, Badcock PB, Cox GR, Merry SN, Meader N. New generation antidepressants for depression in children and adolescents: a network meta-analysis. Cochrane Database Syst Rev. 2021 May 24;5(5):CD013674. doi: 10.1002/14651858.CD013674.pub2. Epub 2021 May 24. PMID: 34029378; PMCID: PMC8143444.

  • * Yatham LN, Arumugham SS, Kesavan M, Ramachandran K, Murthy NS, Saraf G, Ouyang Y, Bond DJ, Schaffer A, Ravindran A, Ravindran N, Frey BN, Daigneault A, Beaulieu S, Lam RW, Kondapuram N, Reddy MS, Bhandary RP, Ashok MV, Ha K, Ahn YM, Milev R, Wong H, Reddy YCJ, BEAM-BD Trial Group. Duration of Adjunctive Antidepressant Maintenance in Bipolar I Depression. N Engl J Med. 2023 Aug 3;389(5):430-440. doi: 10.1056/NEJMoa2300184. PMID: 37530824.

  • * Salian HH, Raghav MV, Rawat VS, Divakar A. Cost-minimization analysis of escitalopram, fluoxetine, and amitriptyline in the treatment of depression. Indian J Pharmacol. 2023 Sep-Oct;55(5):293-298. doi: 10.4103/ijp.ijp_854_22. PMID: 37929407; PMCID: PMC10751525.

  • * Kessing LV, Ziersen SC, Andersen FM, Gerds T, Budtz-Jørgensen E. Comparative responses to 17 different antidepressants in major depressive disorder: Results from a 2-year long-term nation-wide population-based study emulating a randomized trial. Acta Psychiatr Scand. 2024 May;149(5):378-388. doi: 10.1111/acps.13673. Epub 2024 Feb 20. PMID: 38379028.

  • * Chen A, Metzger E, Lee S, Osser D. A Proposed Algorithm for the Pharmacological Treatment of Generalized Anxiety Disorder in the Older Patient. J Geriatr Psychiatry Neurol. 2025 May;38(3):155-171. doi: 10.1177/08919887241289533. Epub 2024 Oct 1. PMID: 39352792.

  • * Chatterjee SS, Mukherjee S, Das S, Kayal M, Mondal S. Quetiapine Extended-Release and Peripheral Edema: A Case Report and Literature Review. Case Rep Psychiatry. 2025;2025:5806365. doi: 10.1155/crps/5806365. Epub 2025 Oct 31. PMID: 41211119; PMCID: PMC12595240.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.